ATE240346T1 - Leberspezifische gallensaeurederivate des antiglukokorticoids ru486 - Google Patents

Leberspezifische gallensaeurederivate des antiglukokorticoids ru486

Info

Publication number
ATE240346T1
ATE240346T1 AT00922530T AT00922530T ATE240346T1 AT E240346 T1 ATE240346 T1 AT E240346T1 AT 00922530 T AT00922530 T AT 00922530T AT 00922530 T AT00922530 T AT 00922530T AT E240346 T1 ATE240346 T1 AT E240346T1
Authority
AT
Austria
Prior art keywords
antiglucorcorticoid
liver
acid derivatives
bile acid
specific bile
Prior art date
Application number
AT00922530T
Other languages
English (en)
Inventor
Theresa Apelqvist
Jinchang Wu
Konrad F Koehler
Original Assignee
Karobio Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karobio Ab filed Critical Karobio Ab
Application granted granted Critical
Publication of ATE240346T1 publication Critical patent/ATE240346T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00922530T 1999-03-27 2000-03-18 Leberspezifische gallensaeurederivate des antiglukokorticoids ru486 ATE240346T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9907048.4A GB9907048D0 (en) 1999-03-27 1999-03-27 Novel glucocorticoid receptor ligands for the treatment of meta bolic disorders
PCT/EP2000/002429 WO2000058337A1 (en) 1999-03-27 2000-03-18 Liver specific bile acid derivatives of the glucocorticoid antagonist ru486

Publications (1)

Publication Number Publication Date
ATE240346T1 true ATE240346T1 (de) 2003-05-15

Family

ID=10850457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00922530T ATE240346T1 (de) 1999-03-27 2000-03-18 Leberspezifische gallensaeurederivate des antiglukokorticoids ru486

Country Status (13)

Country Link
US (1) US6468975B1 (de)
EP (1) EP1165595B1 (de)
JP (1) JP2002540215A (de)
KR (1) KR20020002486A (de)
AT (1) ATE240346T1 (de)
AU (1) AU758654B2 (de)
CA (1) CA2367792A1 (de)
DE (1) DE60002692T2 (de)
DK (1) DK1165595T3 (de)
ES (1) ES2197091T3 (de)
GB (1) GB9907048D0 (de)
PT (1) PT1165595E (de)
WO (1) WO2000058337A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267898A4 (de) * 2000-04-07 2006-02-01 Univ Maryland Gallensäure enthaltend propharmaka mit erhöhter bioavibilität
CA2488535C (en) * 2002-06-19 2012-02-07 Karo Bio Ab Glucocorticoid receptor ligands for the treatment of metabolic disorders
US7141559B2 (en) 2002-06-19 2006-11-28 Karo Bio Ab Glucocorticoid receptor ligands for the treatment of metabolic disorders
WO2010052445A1 (en) 2008-11-07 2010-05-14 University Of Sheffield Medicament and method of diagnosis
RU2014119787A (ru) 2011-10-25 2015-12-10 Айсис Фармасьютикалс, Инк. Антисмысловая регуляция экспрессии gccr

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441129A (en) 1942-05-23 1948-05-11 Berczeller Arpad Bile acid derivatives of aryl sulfonamides
US4418059A (en) 1981-07-20 1983-11-29 Montefiore Medical Center Nucleoside ester compositions
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
WO1998027986A1 (en) 1996-12-24 1998-07-02 Zymogenetics, Inc. Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
WO1999063976A2 (en) 1998-06-08 1999-12-16 Karo Bio Ab Liver-selective glucocorticoid antagonist for treating diabetes

Also Published As

Publication number Publication date
EP1165595A1 (de) 2002-01-02
EP1165595B1 (de) 2003-05-14
JP2002540215A (ja) 2002-11-26
WO2000058337A1 (en) 2000-10-05
CA2367792A1 (en) 2000-10-05
AU4289300A (en) 2000-10-16
DK1165595T3 (da) 2003-09-15
PT1165595E (pt) 2003-08-29
KR20020002486A (ko) 2002-01-09
AU758654B2 (en) 2003-03-27
DE60002692D1 (de) 2003-06-18
US6468975B1 (en) 2002-10-22
GB9907048D0 (en) 1999-05-19
ES2197091T3 (es) 2004-01-01
DE60002692T2 (de) 2004-03-25

Similar Documents

Publication Publication Date Title
NO20021358D0 (no) Alkylendiamin-substituerte heterocykler
TR200100238T2 (tr) Yeni sübstitüe edilmiş pirazol türevleri
ATE440087T1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
DE60037892D1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
NO20045043L (no) Pyrimidinonforbindelser, sammensetninger og fremgangsmater
WO2005030120A3 (en) Antiangiogenic agents
ATE284853T1 (de) Ureido-thiobuttersäurederivate als ppar-agonisten
ATE304354T1 (de) Kaliumkanal-modulierende imidazolderivate
WO2002042319A3 (en) 2-substituted estrogens as antiangiogenic agents
DE602004007672D1 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
ATE269340T1 (de) Thiazolopyrimidine und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
NZ516397A (en) Aminothiazole derivatives and their use as CRF receptor ligands
ATE240346T1 (de) Leberspezifische gallensaeurederivate des antiglukokorticoids ru486
DE60311887D1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
ATE517626T1 (de) Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen
DE50114181D1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan-verbindungen zur therapie der harninkontinenz
ATE322244T1 (de) Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
ATE298244T1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165595

Country of ref document: EP

REN Ceased due to non-payment of the annual fee